Abstract:Abstract Case A 66-year-old man with history of anxiety, depression, and complex regional pain syndrome presented to a psychiatric hospital with suicidal ideation. Admission laboratory studies demonstrated hypercalcemia (Ca 14.2 mg/dL) with kidney injury (Cr 3.26). He endorsed taking 5 to 16 (average 8-9) tablets of 1000 IU Vitamin D daily for 10 years. He had heard about the health benefits of Vitamin D and believed it gave him a euphoric effect. Work-up demonstrated elevated ionized calcium (1.63 mmol/L), normal serum phosphorus (3.8 mg/dL), low total protein (6.24 g/dL), normal total albumin (3.42 g/dL), and negative serum protein electrophoresis. Intravenous hydration with normal saline at 200 cc/hr was initiated along with intravenous furosemide. Additional work up demonstrated a suppressed parathyroid hormone level (10pg/ml). 25-hydroxyvitamin D3 (25-(OH)D3) levels were elevated beyond the measurable range (> 155.9 pg/mL). The plasma 1α,25-dihydroxyvitamin D3 (1α,25 (OH)2D3) was normal at 44 pg/mL (range 18-64 pg/mL). With intravenous fluid administration, the patient's ionized calcium level decreased and his creatinine improved. However, 48 hours after the fluids were discontinued on hospital day 3, the ionized calcium and serum creatinine rose once again. Due to the long half-life of Vitamin D and the up-trending calcium levels, he received 60mg of intravenous Pamidronate on hospital day 8. On discharge on hospital day 11, his renal function was stable (Cr 2.24) with normal ionized calcium (1.27 mmol/L). His psychiatric symptoms had resolved. Discussion The two most common causes of hypercalcemia are primary hyperparathyroidism and malignancy. Less commonly, vitamin D-mediated hypercalcemia may result from ectopic 1,25-dihydroxyvitamin D production or excessive Vitamin D ingestion. The known upper limit of daily Vitamin D intake in an adult that will cause no adverse risk is 4000 IU per day. Vitamin D is a fat-soluble vitamin with a half-life of approximately 2 months. The liver converts Vitamin D3 to the metabolite 25-(OH)D3, which has a half-life of 15 days, and the kidney further metabolizes this to 1α,25 (OH)2D3, which has a half-life of 15 hours. Therefore, this patient's 25-(OH)D3 was expected to remain at toxic levels for an unknown time period, placing him at risk of prolonged hypercalcemia with further deterioration of his renal function. There is no standard of care established for patients with vitamin D toxicity. Pamidronate, normally contraindicated for GFR <30 mL/min, was administered after nephrology consultation. Information about vitamin D toxicity is primarily gleaned from case reports and series. This case report serves as a model for study of Vitamin D toxicity in humans for understanding the long-term management in patients with chronic vitamin D toxicosis presenting with renal failure. Presentation: No date and time listed

Calcium carbonate toxicity: the updated milk-alkali syndrome; report of 3 cases and review of the literature

Milk-Alkali Syndrome as a Cause of Hypercalcemia in a Gentleman With Acute Kidney Injury and Excessive Antacid Intake

Too Much of a Good Thing: Severe Hypercalcemia Presenting with Lethargy and Kidney Failure

A case of advanced chronic kidney disease with severe hypocalcemia, how to safely manage and dialyze?

A Challenging Case of Vitamin D Toxicity Responding to Cinacalcet

Too much of a good thing: A case series of rare yet pertinent causes of hypercalcaemia and acute kidney injury

A Case of Delirium Induced by Milk-Alkali Syndrome in the Elderly

Persistent Mild Anemia and Hypercalcemia were Ignored as Normal Reaction Secondary to Oral Calcium Supplementation in a Steroid-Dependent Asthma Patient Ultimately Diagnosed as Multiple Myeloma: a Case Report and Literature Review

LBODP020 Treatment Of Hypercalcemia Due To Prolonged, Excessive Vitamin D Intake

An infant developing hypercalcemia and hypophosphatemia due to the use of exclusively almond milk

A Curious Case of Severe Recurrent Hypocalcemia

METABOLIC ALKALEMIA IN HYPERCALCIURIA STONE FORMERS: DOES IT MATTER?

[Update - Calcium Metabolism]

Vitamin D toxicity from an unusual and unexpected source: a report of 2 cases

Recalcitrant hypercalcemia in a dialysis patient: Case report, literature review, and proposed management algorithm

Vitamin D and Calcium Supplementation and Urolithiasis: A Controversial and Multifaceted Relationship

Vitamin D toxicity resulting from overzealous correction of vitamin D deficiency

Hard water syndrome: a case series of 30 patients from a London haemodialysis unit

Recurrent Disturbance of Consciousness in a Peritoneal Dialysis Patient with Severe Hypercalcemia Caused by Daily Low-Dose Keto Acids Supplementation

Vitamin D Toxicity Managed with Peritoneal Dialysis

Hypercalcemia and hyperosteolysis in vitamin D intoxication: Effects of clodronate therapy